Monaco Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Monaco Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.68M	Sell	3,421,020 -39,170	-1%	-$133K	1.79%	18
2025 Q4	$11.2M	Sell	3,460,190 -196,147	-5%	-$660K	1.95%	14
2025 Q3	$10.5M	Buy	3,656,337 +2,775,372	+315%	+$7.09M	0.64%	16
2025 Q2	$2.12M	Buy	880,965 +45,100	+5%	+$94.8K	0.37%	44
2025 Q1	$1.85M	Buy	835,865 +544,501	+187%	+$2.15M	0.38%	35
2024 Q4	$1.59M	Buy	291,364 +216,364	+288%	+$1.39M	0.23%	48
2024 Q3	$623K	Sell	75,000 -125,000	-63%	-$1.08M	0.09%	62
2024 Q2	$1.43M	Buy	200,000 +41,849	+26%	+$361K	0.23%	38
2024 Q1	$1.37M	Sell	158,151 -153,059	-49%	-$1.04M	0.41%	38
2023 Q4	$2.04M	Buy	+311,210	New	+$2.01M	0.6%	41

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Monaco Asset Management's MRVI Position: Q1 2026 in Review

Monaco Asset Management reduced its Maravai LifeSciences (MRVI) stake by 1.1% in Q1 2026, selling an estimated $133K and leaving 3,421,020 shares worth $9.68M. The position accounts for 1.79% of the portfolio, ranked #18.

Monaco Asset Management first reported a position in MRVI in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.2M in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Monaco Asset Management held 3,421,020 shares of Maravai LifeSciences worth $9.68M as of Q1 2026.
Monaco Asset Management sold 39,170 Maravai LifeSciences shares in Q1 2026, an estimated $133K.
Maravai LifeSciences made up 1.79% of Monaco Asset Management's portfolio in Q1 2026, its #18 holding.
Monaco Asset Management first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 10 quarters since.
Monaco Asset Management's Maravai LifeSciences position peaked at $11.2M in Q4 2025.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Monaco Asset Management's 13F filing for Q1 2026, filed 11 May 2026.